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Abstract Three phenotypically distinct cell types are
present in human neuroblastomas (NB) and NB cell lines:
I-type stem cells, N-type neuroblastic precursors, and S-
type Schwannian/melanoblastic precursors. The stimulation
of human N-type neuroblastoma cell proliferation by
normal human bone marrow monocytic cell conditioned
medium (BMCM) has been demonstrated in vitro, a finding
consistent with the high frequency of bone marrow (BM)
metastases in patients with advanced NB. Inorganic arsenic
trioxide (As2O3), already clinically approved for the
treatment of several hematological malignancies, is cur-
rently under investigation for NB. Recent studies show that
As2O3 induces apoptosis in NB cells. We examined the
impact of BMCM on growth and survival of As2O3-treated
NB cell lines, to evaluate the response of cultured NB cell
variants to regulatory agents. We studied the effect of
BMCM on survival and clonogenic growth of eleven
As2O3-treated NB cell lines grown in sparsely seeded,
non-adherent, semi-solid cultures. As2O3 had a strong
inhibitory effect on survival of all tested NB cell lines.
BMCM augmented cell growth and survival and reversed
the inhibitory action of As2O3 in all tested cell lines, but
most strongly in N-type cells. While As2O3 effectively
reduced survival of all tested NB cell lines, BMCM
effectively impacted its inhibitory action. Better under-
standing of micro-environmental regulators affecting hu-
man NB tumor cell growth and survival may be seminal to
the development of therapeutic strategies and clinically




Neuroblastoma (NB), the most common extra-cranial solid
tumor of childhood, arises in the developing neural crest
[1]. Although intensive chemotherapy and radiotherapy
supported by bone marrow transplantation and retinoic acid
treatment have improved survival, most advanced NB
patients eventually develop progressive disease, refractory
to continued therapy [2]. Consistent with their origin from
multi-potent neural crest cells, tumors often consist of
multiple cell phenotypes [3]. Examination of the cellular
heterogeneity and malignant potential of human NB cell
lines and clones supports the observation that phenotypes
characterized in cell lines are present in tumors [4]. Studies
of NB cell growth, differentiation, and malignancy have
resulted in the identification of three distinct cellular
phenotypes [4]: (1) I-type stem cells, (2) S-type substrate-
adherent, Schwannian/melanoblastic precursors, and (3) N-
type neuroblastic/neuroendocrine precursors. I-type stem
cells are exquisitely anchorage-independent and highly
efficient in the formation of colonies in semi-solid medium.
As assessed by tumor formation in nude mice, and
anchorage-independent growth in soft agar, I-type stem cells
are significantly more malignant than either N- or S-type
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Rehovot, Israelcells [4]. N- and S-type cells are anchorage-dependent: N
cells form colonies with low efficiency, while S cells grow
poorly, if at all, in non-adherent, semi-solid cultures [4].
Bone marrow (BM) is the most common site of metastasis
in NB, occurring in about 70% of metastatic NB patients [5].
Clinically, this stage is often associated with refractory
disease and fatal outcome. The relatively high frequency of
BM metastases in patients with advanced NB suggests the
presence of BM micro-environmental elements that are
favorable to NB tumor cell growth. We have previously
presented evidence of pronounced augmentation of N-type
NB cell colony formation in semi-solid non-adherent
cultures, elicited by conditioned media from normal human
BM monocytic cell cultures [6]. More recently, inorganic
arsenic trioxide (As2O3) has been clinically approved for
the treatment of several hematologic malignancies [7–9]
and is currently under investigation for NB [10]. Recent
reports have conclusively shown that As2O3 exerts its
action through apoptotic processes while studies with cell
lines show that As2O3 has a similar apoptotic effect on NB
cells to that on malignant hematopoietic cells [10–14].
On the basis of clinical studies showing that As2O3
induces remission with minimal toxicity in patients with
BM-related malignant diseases (acute promyelocytic leuke-
mia and multiple myeloma) by apoptotic mechanisms [7–
9], we evaluated the impact of BMCM on growth and
survival of As2O3-treated NB cell lines, representing each
of the NB cell types described above.
Methods
Cells Five N-type (IMR 32, IMR 5, KELLY, SY5Y, SK-N-
SH), three I-type (NUB 6, MC, LAN 5) and three S-type
(SHEP, SK-N-LO, LS) well established human NB cell
lines were maintained in RPMI 1640 medium containing
10% fetal bovine serum.
Preparation of BMCM BM samples were obtained by
informed consent from normal healthy adult donors. Low-
density cells were suspended in serum-free RPMI 1640
culture medium (Biological Industries, Bet Haemek, Israel),
at 5×10
6 cells/ml and incubated for 96 h. Cell-free
conditioned medium (CM) was obtained by centrifugation
and filtration of the 96-h incubated culture medium and
tested for activity.
To Measure Cell Viability Cell lines (2×10
4 cells/ml) were
incubated for 24 h in non-adherent cultures with or without
0.6, 1.2, 2.5 and 5 μMA s 2O3 (Sigma) and/or 1.2, 2.5, 5,
and 10% BMCM. Using XTT reagent (Biological Indus-
tries, Bet Haemek, Israel), survival was quantified by
colorimetric measurement of mitochondria-mediated
tetrazolium salt reduction, resulting in colored formazan
compounds [15]. Disruption of the mitochondrial trans-
membrane potential is one of the early intracellular events
to occur following induction of apoptosis. A decrease in
cellular ability to reduce XTT, a yellow water-soluble
tetrazolium salt, 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-
5-tetrazolio]-1,3-benzene disulfonate, is widely used for the
colorimetric non-radioactive quantification of cellular via-
bility. This tetrazolium salt is cleaved to formazan by the
“succinate-tetrazolium reductase” system (EC1.3.99.1)
which belongs to the respiratory chain of the mitochondria
and is active only in metabolically active cells. The rate of
tetrazolium reduction is proportional to the extent of cell
viability [15].
The results (mean±SD) of triplicate cultures represent
absorbance at 450 nm after 5 h incubation with XTT.
To Determine Colony Formation As previously described
[6], cells were seeded at 500 cells/ml in semi-solid non-
adherent cultures with or without As2O3 and/or BMCM at
the above concentrations. Colonies were counted after 8–
10 days of incubation. All determinations were done in
triplicate and are presented as mean±SD.
Results
BMCM Inhibits As2O3-induced Cell Death
In agreement with recent reports, we observed that in the
micro-molar range As2O3 had a concentration-dependent
cytotoxic effect on the 11 cell lines representing all three
NB cell types. To examine the impact of BMCM on As2O3-
induced cell death, non-adherent cultures of three I-type
(NUB 6, MC, LAN 5), three S-type (SHEP, SK-N-LO, LS)
and five N-type (IMR 32, IMR 5, KELLY, SY5Y, SK-N-
SH) NB cell lines were incubated for 24 h with increasing
concentrations of both BMCM and As2O3. Viability was
strongly reduced in all five of the anchorage-dependent N-
type cell lines in non-adherent cultures in the absence of
both As2O3 and BMCM. Fig. 1a shows the results of four
out of five cell lines (SK-N-SH not shown). Addition of
increasing concentrations of BMCM, without As2O3, to the
culture medium resulted in significantly increased cell
viability. As2O3 at 2.5 μM considerably reduced viability
in all five cell lines treated with a low 2.5% concentration
of BMCM, while higher BMCM concentrations (5% and
10%) considerably reduced or abrogated this cytotoxic
action of As2O3 at 2.5 μM (Fig. 1a). As2O3 at 5 μM,
however, was cytotoxic to the same extent regardless of
BMCM.
Consistent with their anchorage-independence, the I-type
celllines survivedwellinnon-adherentcultures intheabsence
154 B. Gesundheit et al.of BMCM (Fig. 1b). In contrast to N-type cells, BMCM
increased cell survival only very slightly, and As2O3-induced
cytotoxicity wasalso weaker than in theother cell types. None
the less, similarly to the other cell types, BMCM reduced the
cytotoxic activity of As2O3 in I-type cells (Fig. 1b).
Despite their anchorage dependence, untreated S-type
cells survived in non-adherent cultures while a concentra-
tion of 2.5 μMA s 2O3 was sufficient to reduce viability in
all three S-type cell lines. Increasing concentrations of
BMCM, however, effectively reversed this As2O3-induced
cytotoxic action (Fig. 1c).
BMCM Reverses As2O3-induced Inhibition
of Colony Formation
As we have previously reported [6], anchorage-dependent
N-type cell lines failed to form colonies in sparsely seeded
semi-solid cultures without BMCM (Fig. 2a). Consistent
with its cytotoxic activity, As2O3 caused considerable dose-
dependent inhibition of BMCM-induced NB cell colony
formation by all five of the anchorage-dependent N-type
cell lines. Figure 2a shows the results of four out of five N-
type cell lines (results of SY5Y not shown). At increasing
concentrations of BMCM, higher concentrations of As2O3
were required to successfully inhibit cell growth of all five
cell lines tested.
Figure 2b demonstrates the reversal of As2O3 inhibitory
action on anchorage-independent I-type cell colony forma-
tion. In contrast to N-type cells, these cells form colonies
very efficiently in semi-solid medium in the absence of
BMCM. In the presence of increasing concentrations of
BMCM, however, As2O3-induced inhibitory action is
considerably reversed.
Discussion
Malignant cells from solid tumors often metastasize to the
bone marrow (BM). In patients with neuroblastoma,
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Fig. 1 Dose-dependent inhibi-
tion of As2O3-induced cell
death by BMCM (at concentra-




I-type cells. c Anchorage-
dependent S-type cells. Viability
was quantified, using the XTT
reagent by colorimetric mea-
surement of mitochondria-
mediated tetrazolium salt
reduction, resulting in colored
formazan compounds. The
results (mean±SD) of triplicate
cultures represent absorbance at
450 nm after 5 h incubation
with XTT
BM cell factor inhibits As2O3-induced death of NB cells 155than at any other site; indeed, more than 70% of patients
with NB have BM metastases at diagnosis of stage IV
disease, with a significantly poorer prognosis [5]. Our
previous report provides evidence that non-stimulated low-
density BM cells release activity which strongly augments
proliferation of N-type cell lines derived from human NB
tumors [6]. This finding is consistent with the relatively
high frequency of BM metastases in patients with advanced
NB. Cells from various types of tumors, similarly to N-type
NB cells, are anchorage-dependent. By detachment from
the primary tumor they are deprived of vital adhesion
signals. Denial of their extra-cellular matrix causes these
cells to undergo programmed cell death [16]. This
detachment-induced apoptosis may provide protection
against the metastatic spread of tumor cells. To mimic such
detachment from the matrix in vitro, we used culture
conditions under which cells could not attach themselves to
a surface or to each other. In the case of N-type NB cells,
this resulted in cell death within 24 h. Our study provides
evidence that the presence of BMCM in non-adherent
sparsely seeded cultures increases viability of anchorage-
dependent N-type cells and thereby enables them to form
colonies. In contrast, anchorage-independent I-type NB
cells, which were unaffected by the absence of adhesion,
survived and formed similar numbers of colonies regardless
of whether BMCM was present or absent. Treatment with
As2O3 dose-dependently reduced viability and inhibited
growth of all the I-type cell lines, and of all of the BMCM-
treated N-type cell lines. Increasing the concentration of
BMCM in these cultures, however, resulted in the reversal
of the inhibitory action of As2O3.
N and I-type cells, similarly to neuronal cells, produce
neurotransmitters and grow as aggregates of small round
cells with neuritic processes, In contrast, S-type cells are
devoid of neurotransmitter synthesis and are larger, flat-
tened and substrate-adherent, resembling epithelial or
fibroblast cells. Previous studies have shown that growth
arrest induced by suspension of certain fibroblasts does not
result in apoptosis and indeed may be reversible [17]. We
have previously shown that, in contrast to anchorage-
dependent N-type cells and similarly to fibroblasts, colony
formation by S-type cells was not induced by BMCM [18].
Despite these discrepancies, As2O3 effectively reduced the
survival of all three S-type cell lines while increasing
concentrations of BMCM resulted in the reversal of As2O3
activity (Fig. 1c).
Preparations of BMCM are presently being subjected to
procedures for the isolation of the molecular mediator of
the activity described above. Isolation and identification of
the agent(s) responsible for this potent regulatory activity in
Anchorage-dependent N-type cells A.  
Anchorage-independent I-type cells. B.  
BMCM (%)
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Fig. 2 BMCM reverses As2O3-
induced inhibition of colony
formation. Cells were seeded at
500 cells/ml in semi-solid non-
adherent cultures±As2O3 and/or
BMCM at the above concentra-
tions. Colonies were counted
after 8–10 days of incubation.
All determinations were done in
triplicate and are presented as
mean±SD
156 B. Gesundheit et al.BM CM may be useful for devising strategies for the
detection of responsive NB primary tumor cells and may be
crucial for the development of more effective therapeutic
strategies for this often fatal disease.
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